Variant report
Variant | esv2755364 |
---|---|
Chromosome Location | chr2:51734676-51792813 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:118)
- CpG islands (count:0)
- Chromatin interactive region (count:9)
- LncRNA region (count:2)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr2:51734641-51734960 | HepG2 | liver: | n/a | chr2:51734787-51734796 chr2:51734785-51734796 chr2:51734785-51734798 chr2:51734787-51734796 chr2:51734784-51734801 chr2:51734787-51734796 chr2:51734787-51734796 chr2:51734786-51734797 |
2 | CEBPB | chr2:51734659-51734923 | A549 | lung: | n/a | chr2:51734787-51734796 chr2:51734785-51734796 chr2:51734785-51734798 chr2:51734787-51734796 chr2:51734784-51734801 chr2:51734787-51734796 chr2:51734787-51734796 chr2:51734786-51734797 |
3 | CEBPB | chr2:51734625-51735863 | IMR90 | lung: | n/a | chr2:51734787-51734796 chr2:51734785-51734796 chr2:51734785-51734798 chr2:51734787-51734796 chr2:51734784-51734801 chr2:51734787-51734796 chr2:51734787-51734796 chr2:51734786-51734797 |
4 | CTCF | chr2:51737260-51737410 | BE2_C | brain: | n/a | n/a |
5 | CTCF | chr2:51752332-51752370 | LNCaP | prostate: | n/a | n/a |
6 | CTCF | chr2:51792660-51792810 | AG04449 | skin: | n/a | n/a |
7 | CTCF | chr2:51761725-51761750 | ProgFib | skin: | n/a | n/a |
8 | CTCF | chr2:51737136-51737281 | IMR90 | lung: | n/a | n/a |
9 | CTCF | chr2:51737160-51737310 | HCPEpiC | choroid plexus: | n/a | n/a |
10 | CTCF | chr2:51737180-51737330 | HCPEpiC | choroid plexus: | n/a | n/a |
11 | CTCF | chr2:51754400-51754550 | HBMEC | blood vessel: | n/a | n/a |
12 | CTCF | chr2:51737180-51737330 | AG04449 | skin: | n/a | n/a |
13 | CUX1 | chr2:51750308-51750374 | GM12878 | blood: | n/a | n/a |
14 | E2F4 | chr2:51743896-51744096 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | ELF1 | chr2:51738202-51738481 | GM12878 | blood: | n/a | n/a |
16 | EP300 | chr2:51761338-51761626 | SK-N-SH_RA | brain: | n/a | n/a |
17 | EP300 | chr2:51761264-51761537 | SK-N-SH_RA | brain: | n/a | n/a |
18 | EP300 | chr2:51762651-51763696 | SK-N-SH | brain: | n/a | n/a |
19 | EP300 | chr2:51763145-51763430 | SK-N-SH_RA | brain: | n/a | n/a |
20 | FOS | chr2:51735022-51735236 | MCF10A-Er-Src | breast: | n/a | chr2:51735077-51735086 |
21 | FOS | chr2:51735014-51735214 | MCF10A-Er-Src | breast: | n/a | chr2:51735077-51735086 |
22 | FOS | chr2:51743860-51744187 | MCF10A-Er-Src | breast: | n/a | n/a |
23 | FOS | chr2:51740613-51740643 | MCF10A-Er-Src | breast: | n/a | n/a |
24 | FOS | chr2:51752929-51753003 | MCF10A-Er-Src | breast: | n/a | chr2:51752963-51752972 chr2:51752965-51752972 chr2:51752964-51752972 |
25 | FOS | chr2:51754209-51754532 | HUVEC | blood vessel: | n/a | chr2:51754370-51754381 |
26 | FOS | chr2:51754192-51754524 | MCF10A-Er-Src | breast: | n/a | chr2:51754370-51754381 |
27 | FOS | chr2:51754218-51754535 | MCF10A-Er-Src | breast: | n/a | chr2:51754370-51754381 |
28 | FOS | chr2:51754207-51754540 | MCF10A-Er-Src | breast: | n/a | chr2:51754370-51754381 |
29 | FOS | chr2:51735035-51735312 | MCF10A-Er-Src | breast: | n/a | chr2:51735077-51735086 |
30 | FOS | chr2:51743718-51744652 | HUVEC | blood vessel: | n/a | n/a |
31 | FOS | chr2:51734673-51735620 | HUVEC | blood vessel: | n/a | chr2:51735077-51735086 |
32 | FOS | chr2:51755235-51755467 | MCF10A-Er-Src | breast: | n/a | n/a |
33 | FOS | chr2:51754191-51754543 | MCF10A-Er-Src | breast: | n/a | chr2:51754370-51754381 |
34 | GATA2 | chr2:51743705-51744627 | HUVEC | blood vessel: | n/a | n/a |
35 | GATA2 | chr2:51761384-51761754 | SH-SY5Y | brain: | n/a | n/a |
36 | GATA2 | chr2:51769400-51769721 | SH-SY5Y | brain: | n/a | n/a |
37 | IRF1 | chr2:51788298-51788308 | K562 | blood: | n/a | n/a |
38 | JUN | chr2:51779040-51779240 | K562 | blood: | n/a | n/a |
39 | JUN | chr2:51734961-51735624 | HUVEC | blood vessel: | n/a | chr2:51735077-51735086 |
40 | JUN | chr2:51743830-51744204 | HUVEC | blood vessel: | n/a | n/a |
41 | JUN | chr2:51754204-51754445 | HepG2 | liver: | n/a | n/a |
42 | JUND | chr2:51754187-51754554 | HepG2 | liver: | n/a | chr2:51754370-51754381 |
43 | JUND | chr2:51754271-51754429 | H1-hESC | embryonic stem cell: | n/a | chr2:51754370-51754381 |
44 | JUND | chr2:51748111-51748408 | HepG2 | liver: | n/a | chr2:51748250-51748259 |
45 | JUND | chr2:51752880-51753118 | HepG2 | liver: | n/a | chr2:51752963-51752972 chr2:51752962-51752973 chr2:51752965-51752972 chr2:51752964-51752972 |
46 | JUND | chr2:51763101-51763280 | HepG2 | liver: | n/a | chr2:51763214-51763225 |
47 | MAFF | chr2:51762963-51763252 | HepG2 | liver: | n/a | n/a |
48 | MAFF | chr2:51753923-51754272 | K562 | blood: | n/a | chr2:51754088-51754106 chr2:51754094-51754108 |
49 | MAFF | chr2:51791497-51791650 | HepG2 | liver: | n/a | chr2:51791565-51791583 |
50 | MAFF | chr2:51753915-51754287 | HepG2 | liver: | n/a | chr2:51754088-51754106 chr2:51754094-51754108 |
No data |
(count:9 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 2:51664217-51674289..2:51745267-51754233 | H1-hESC | embryonic stem cell: | embryo |
2 | 2:51755125-51764739..2:52034460-52043624 | K562 | blood: | |
3 | 2:51733860-51734854..2:51736485-51737129 | GM12878 | blood: | |
4 | 2:51664217-51674289..2:51733860-51734854 | H1-hESC | embryonic stem cell: | embryo |
5 | 2:51745267-51754233..2:52043624-52043909 | K562 | blood: | |
6 | 2:51785137-51786126..2:52106672-52112664 | GM12878 | blood: | |
7 | 2:51664217-51674289..2:51764739-51769547 | H1-hESC | embryonic stem cell: | embryo |
8 | 2:51745267-51754233..2:52106672-52112664 | GM12878 | blood: | |
9 | 2:51733860-51734854..2:51736485-51737129 | GM12878 | blood: |
(count:2 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-CHAC2-4 | chr2:51754740-51754798 | ENSG00000231918.1 |
2 | lnc-CHAC2-12 | chr2:51738196-51738621 | NONHSAT070659 |
No data |
No data |
Variant related genes | Relation type |
---|---|
KNOP1P3 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs1528804 | chr2:51734676-51734677 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs138946511 | chr2:51734680-51734681 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs7603619 | chr2:51734686-51734687 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs28958294 | chr2:51734752-51734753 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
5 | rs572020507 | chr2:51734765-51734766 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs550656732 | chr2:51734786-51734787 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs377176398 | chr2:51734835-51734836 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs539215508 | chr2:51734877-51734878 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs7564790 | chr2:51734924-51734925 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs186472391 | chr2:51734964-51734965 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs536367469 | chr2:51734975-51734976 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs143901421 | chr2:51735051-51735052 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs567870277 | chr2:51735056-51735057 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs529102118 | chr2:51735072-51735073 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs1919424 | chr2:51735079-51735080 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs558425387 | chr2:51735128-51735129 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs576755209 | chr2:51735131-51735132 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs68052961 | chr2:51735133-51735134 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs550843085 | chr2:51735134-51735135 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs1919426 | chr2:51735138-51735139 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs546591549 | chr2:51735147-51735148 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs529695818 | chr2:51735183-51735184 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs566740077 | chr2:51735208-51735209 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs541570892 | chr2:51735230-51735231 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs201544037 | chr2:51735238-51735239 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs13415393 | chr2:51735239-51735240 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs185180249 | chr2:51735244-51735245 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs191560929 | chr2:51735263-51735264 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs563439043 | chr2:51735277-51735278 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs182897736 | chr2:51735291-51735292 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs530424584 | chr2:51735327-51735328 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
32 | rs188819118 | chr2:51735344-51735345 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs565564625 | chr2:51735368-51735369 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs532873043 | chr2:51735376-51735377 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs555726910 | chr2:51735435-51735436 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs547981297 | chr2:51735462-51735463 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs566278675 | chr2:51735485-51735486 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs1919427 | chr2:51735494-51735495 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
39 | rs148608057 | chr2:51735511-51735512 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs537957287 | chr2:51735549-51735550 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs2698009 | chr2:51735564-51735565 | Enhancers | TF binding region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs577838118 | chr2:51735570-51735571 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs143297418 | chr2:51735585-51735586 | Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
44 | rs558562576 | chr2:51735721-51735722 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs550454098 | chr2:51735740-51735741 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
46 | rs576691404 | chr2:51735745-51735746 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
47 | rs146220067 | chr2:51735769-51735770 | Enhancers Weak transcription | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
48 | rs552710306 | chr2:51735811-51735812 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
49 | rs115976360 | chr2:51735821-51735822 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
50 | rs192920587 | chr2:51735844-51735845 | Weak transcription Enhancers | TF binding region | 1 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 22495311 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Williams Syndrome | 20824207 | CNVD |
Breast cancer | 16272173 | CNVD |
Lung cancer | 17297452 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Ovarian cancer | 21720365 | CNVD |
abnormal development | 18461090 | CNVD |
Schizophrenia | 20433910 | CNVD |
Autism | 21701786 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Austim spectrum disorder | 21302340 | CNVD |
Schizophrenia | 20587603 | CNVD |
Schizophrenia | 20553308 | CNVD |
Autism | 22241247 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung adenocarcinoma | 17086460 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Cancer | 21183584 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 18768390 | CNVD |
Mental retardation | 19521722 | CNVD |
Schizophrenia | 18990708 | CNVD |
Schizophrenia | 18940311 | CNVD |
Schizophrenia | 19348701 | CNVD |
Schizophrenia | 18945720 | CNVD |
Schizophrenia | 19571808 | CNVD |
Prostate cancer | 16573809 | CNVD |
Neuroticism | 17667963 | CNVD |
Schizophrenia | 19443537 | CNVD |
Schizophrenia | 19546859 | CNVD |
Autism | 17322880 | CNVD |
Lung cancer | 17086460 | CNVD |
Chronic lymphocytic leukemia | 17053054 | CNVD |
Hereditary non-polyposis colorectal cancer | 19566914 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Non-syndromic sensorineural hearing loss | 21293372 | CNVD |
Medulloblastoma | 21163964 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:51734600-51735800 | Enhancers | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
2 | chr2:51734600-51736000 | Enhancers | HUVEC | blood vessel |
3 | chr2:51734600-51736000 | Enhancers | NH-A | brain |
4 | chr2:51734600-51736000 | Enhancers | Osteobl | bone |
5 | chr2:51735000-51735600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
6 | chr2:51735600-51740200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
7 | chr2:51736000-51737400 | Weak transcription | HUVEC | blood vessel |
8 | chr2:51737200-51737600 | Enhancers | IMR90 fetal lung fibroblasts Cell Line | lung |
9 | chr2:51737400-51737800 | Enhancers | HUVEC | blood vessel |
10 | chr2:51740200-51740600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr2:51740600-51741800 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr2:51741800-51742400 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
13 | chr2:51743600-51743800 | Enhancers | HUVEC | blood vessel |
14 | chr2:51743800-51744000 | Flanking Active TSS | HUVEC | blood vessel |
15 | chr2:51744000-51744200 | Enhancers | HUVEC | blood vessel |
16 | chr2:51744200-51744400 | Flanking Active TSS | HUVEC | blood vessel |
17 | chr2:51744400-51744800 | Enhancers | HUVEC | blood vessel |
18 | chr2:51744800-51745800 | Weak transcription | HUVEC | blood vessel |
19 | chr2:51745000-51746800 | Enhancers | Pancreatic Islets | Pancreatic Islet |
20 | chr2:51746000-51746200 | Enhancers | HUVEC | blood vessel |
21 | chr2:51746800-51748200 | Weak transcription | Pancreatic Islets | Pancreatic Islet |
22 | chr2:51748200-51748400 | Enhancers | Pancreatic Islets | Pancreatic Islet |